A2 Milk (ASX:A2M) share price drops amid reported second class action

A2 Milk shares are falling as there's reportedly another class action on the cards.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The A2 Milk Company Ltd (ASX: A2M) share price is currently down amid news of a second class action against the company.

A sobbing businessman accused of wrongdoing faces justice

Image source: Getty Images

Another class action?

The company announced to the ASX that it's aware of media reporting about a potential class action against the company that is apparently being investigated by Shine Justice Ltd (ASX: SHJ).

However, A2 Milk said it's not aware of any legal proceeding having been filed by Shine Lawyers.

The company noted again that it believes it has, at all times, complied with disclosure obligations, denies any liability and will vigorously defend against any proceedings. It said it will respond further if and when any legal action is launched.

What are the allegations by Shine Lawyers?

The class action by Shine alleges that between 19 August 2020 and 7 May 2021, A2 Milk engaged in "misleading and deceptive" conduct, breaching its continuous disclosure obligations, and failing to adequately disclose future trade plans.

Shine also alleges that by 19 August 2020, A2 Milk was, or ought to have been aware that the FY21 guidance, and subsequent announcements, did not adequately take into account a number of factors known to the company which ultimately impacted the company's financial performance. This led to a 62% drop in the A2 Milk share price.

There were two factors that A2 Milk referred to.

First, the decline in reseller/daigou sales, which reportedly fell due to the impact of A2 Milk's sales through its cross border e-commerce channel. Shine noted that this saw A2 Milk heavily market English-labelled infant products directly into the Chinese market with discounting that "effectively undercut" sales in the daigou/reseller channel.

Second, Shine also referred to the decline in the CBEC business due to the drop in the daigou/reseller sales. Shine said that daigou sales often help stimulate demand for direct orders.

Two class actions

This is the second class action that A2 Milk is facing.

The lawyer group Slater & Gordon Limited (ASX: SGH) has also launched a class action. This occurred earlier in October.

Shine's class action alleges similar sorts of things that the Slater & Gordon one does.

Slater & Gordon said:

The proceeding alleges that by no later than 19 August 2020, A2 Milk was or ought to have been aware that the FY21 guidance and subsequent representations did not adequately take account of a number of factors which would impact the company's financial performance.

What is the latest guidance from A2 Milk?

FY21 has finished, but guidance for FY22 can have an impact on the A2 Milk share price.

In its FY21 result, A2 Milk said that its revenue fell 30.3% to $1.21 billion and net profit after tax (NPAT) had dropped 79.1% to $80.7 million.

Whilst the company said it wasn't going to provide specific guidance, it said that it's confident in the underlying fundamentals of the business and that the growth opportunity in core markets remains "significant". The company also said there are opportunities for product innovation, category expansion and new markets. It said the long-term outlook is positive.

However, it also said that there is continuing uncertainty and volatility in consumer markets due to COVID-19, and other rapidly changing market dynamics, particularly in China.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Three brightly coloured objects against a backdrop of blue, indication three winning ASX share prices
Share Gainers

Here are the top 10 ASX 200 shares today

It was a lacklustre session on the ASX this Thursday.

Read more »

a couple consider the advice from a man with documents laid out on a table and the man holding a tablet in his hand.
Financial Shares

3 ASX 200 financial shares to sell: experts

ASX 200 financial shares are down 2.5% over six months and up 2.1% in 2026-to-date.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: NextDC, Hub24, PLS Group shares

The market is pessimistic about the next round of talks between the US and Iran.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

5 ASX 200 shares with renewed buy ratings this week

Brokers have indicated continuing confidence in Cochlear, REA, and several other ASX 200 shares.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Share Gainers

Why Deep Yellow, Develop Global, Resolute Mining, and Santos shares are pushing higher today

These shares are catching the eye on Thursday. But why?

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Black Cat, Mirvac, Qantas, and Temple & Webster shares are falling today

These shares are having a tough session. But why?

Read more »